SUPPORT MPTs
Facebook
Twitter

MPT Product Development Database

This database includes MPT products that are currently available, as well as MPT products in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Click here to learn more about the inclusion criteria and information update methodology.
Help us keep the database complete and up to date!
If you know of an MPT product not included in the database or have updated information for listed products, please contact us using the “MPT Database Feedback” form.
Check out the MPT products in the development pipeline – view an MPT Pipeline Table by Indication Combination.
Product TypeDelivery RouteDelivery MethodDevelopment Stage
       
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
       
Key Word Search   
       

32 product(s) found

Results: 9 product(s) found
Product Name
Product Type
Delivery Route
Delivery Method
Active Ingredient
Developer
Stage
Indication(s)
BioRings TM IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Ascorbic Acid
  • Boc-Lysinated Betulonic Acid
  • Ferrous Gluconate
  • Polyamino-Polycarboxlic Acid
  • Tenofovir (TFV)
    		•
  • BioRings LLC
    		•  P1
  • HIV
  • Pregnancy
    		•
    Dapivirine + Levonorgestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Dapivirine
  • Levonorgestrel
    		•
  • International Partnership for Microbicides (IPM)
    		•  C1
  • HIV
  • Pregnancy
    		•
    Griffithsin (GRFT) IVR (PC-7500) MPT in Development Topical Intravaginal Ring (IVR)
  • Griffithsin (GRFT)
    		•
  • Population Council
    		•  P1
  • HIV
  • HPV
  • HSV-2
    		•
    Tenofovir + IQP-0528 MPT in Development Topical Intravaginal Ring (IVR)
  • IQP-0528
  • Tenofovir (TFV)
    		•
  • ImQuest BioSciences
    		•  P2
  • HIV
  • HSV-2
    		•
    Tenofovir + Levonorgestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Levonorgestrel
  • Tenofovir (TFV)
    		•
  • CONRAD
    		•  C1
  • HIV
  • HSV-2
  • Pregnancy
    		•
    Tenofovir Disoproxil Fumarate (TDF) IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Tenofovir Disoproxil Fumarate (TDF)
    		•
  • Albert Einstein College of Medicine
    		•  C1
  • HIV
  • HSV-2
    		•
    Tenofovir IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Tenofovir (TFV)
    		•
  • CONRAD
    		•  C1
  • HIV
  • HSV-2
    		•
    TFV + Acyclovir + Ethinyl Estradiol + Etonogestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Ethinyl Estradiol
  • Tenofovir (TFV)
    		•
  • Auritec Pharmaceuticals
  • Oak Institute of Science
    		•  P2
  • HIV
  • HSV-2
  • Pregnancy
    		•
    Zinc acetate and carrageenan IVR (ZC IVR) MPT in Development Topical Intravaginal Ring (IVR)
  • Carrageenan
  • Zinc Acetate
    		•
  • Population Council
    		•  P2
  • HIV
  • HPV
  • HSV-2
    		•

    IMPT Secretariat
    308 Natoma Street
    Suite 150
    Folsom, CA 95630
    916-932-4785 | This email address is being protected from spambots. You need JavaScript enabled to view it.

    © Copyright 2016, The IMPT. All rights reserved.

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated to women’s reproductive health and empowerment. CAMI Health is housed at the Public Health Institute (PHI).
    This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.

    CAMI